Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jing Yin Qing Hua Fang
- Development stage
- Unknown
- Lead developer
- Beijing Hospital of Traditional Chinese Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Jing Yin Qing Hua Fang is a Traditional Chinese Medicine (TCM) formula developed by the Beijing Hospital of Traditional Chinese Medicine for the treatment of mild to moderate COVID-19, particularly effective against the Omicron variant. The formula is designed to clear heat, resolve toxicity, and transform dampness, addressing the clinical manifestations of damp-heat syndrome. It consists of a specific blend of herbs including Schizonepeta tenuifolia, Lonicera japonica, and Forsythia suspensa. Pharmacological research suggests that the formula exerts its effects through a multi-target approach, including the suppression of pro-inflammatory cytokines like IL-6 and TNF-α, thereby preventing the progression of the cytokine storm, and potentially inhibiting viral replication. It was authorized as a hospital preparation in Beijing to support the clinical management of the pandemic.
- Brand names
- Jing Yin Qing Hua Fang
- Other names
- Jingyin Qinghua FormulaJingyin Qinghua Decoction荆银清化方
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))Mpro (3C-like proteinase of SARS-CoV-2)IL-6 (Interleukin 6)
Beyond the preview
Go deeper on Jing Yin Qing Hua Fang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jing Yin Qing Hua Fang.